Novel Thiosemicarbazone Derivatives from Furan-2-Carbaldehyde: Synthesis, Characterization, Crystal Structures, and Antibacterial, Antifungal, Antioxidant, and Antitumor Activities

• Autores: Hernández Gorritti, Wilfredo Román, Carrasco Solís, Fernando Carlos, Vaisberg, Abraham, Spodine, Evgenia, Icker, Maik, Krautscheid, Harald
• Formato: artículo
• Fecha de Publicación: 2023
• Institución: Universidad de Lima
• Repositorio: ULIMA-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.ulima.edu.pe:20.500.12724/19426
• Enlace del recurso: https://hdl.handle.net/20.500.12724/19426; https://doi.org/10.1155/2023/5413236
• Nivel de acceso: acceso abierto
• Materia: Thiosemicarbazones; Drugs; Tiosemicarbazonas; Medicamentos; https://purl.org/pe-repo/ocde/ford#2.11.04

Ten new thiosemicarbazone derivatives, furan-2-carbaldehyde thiosemicarbazone (1), 3-methyl-furan-2-carbaldehyde thiosemicarbazone (2), 5-hydroxymethyl-furan-2-carbaldehyde thiosemicarbazone (3), 5-trifluoromethyl-furan-2-carbaldehyde thiosemicarbazone (4), 5-nitro-furan-2-carbaldehyde thiosemicarbazone (5), 5-phenyl-furan-2-carbaldehyde thiosemicarbazone (6), 5-(2-fluorophenyl)-furan-2-carbaldehyde thiosemicarbazone (7), 5-(4-methoxyphenyl)-furan-2-carbaldehyde thiosemicarbazone (8), 5-(1-naphthyl)-furan-2-carbaldehyde thiosemicarbazone (9), and 5-(1H-Pyrazol-5-yl)-furan-2-carbaldehyde thiosemicarbazone (10) were synthesized by condensing thiosemicarbazide with the respective furan-2-carbaldehyde in methanol. The prepared compounds were characterized by spectroscopic studies (FT-IR and NMR) and electrospray mass spectrometry. The molecular structures of 2, 6, 7, and 8 have also been determined by X-ray crystallography. Compounds 2, 6, and 7 crystallize in the E conformation about the N1-C6, N1-C11, and N1-C11 bonds, respectively, while 8 adopts the Z conformation about the N1-C12 bond with the presence of an intramolecular N2-H…O2 hydrogen bond. All prepared thiosemicarbazone derivatives were evaluated for their in vitro antibacterial, antifungal, and antitumor activities against Staphylococcus aureus strains, Candida albicans/Candida tropicalis fungi, and seven human tumor cell lines (HuTu80, H460, DU145, M-14, HT-29, MCF-7, and LNCaP), respectively. The antioxidant activity was also studied by the DPPH assay. Compound 5 exhibited significant antibacterial activity against Staphylococcus aureus ATCC700699 (MIC¿=¿1¿µg/mL) compared to the nitrofurantoin and gentamicin reference drugs (MIC¿=¿1–25 and 10->100¿µg/mL, respectively). Compound 4 was ten times less active than amphotericin B (MIC¿=¿5¿µg/mL) against Candida albicans (ATCC90028 and ATCC10231), while 1 exhibited a moderate effect of scavenging of DPPH radical (IC50¿=¿40.9¿µg/mL) in comparison to ascorbic acid reference compound (IC50¿=¿22.0¿µg/mL). Among all the studied thiosemicarbazones, 5 showed a higher cytotoxic activity (IC50¿=¿13.36–27.73¿µ¿) in relation to the other tested compounds (IC50¿=¿34.84—>372.34¿µ¿) against all tested cell lines, except the LNCaP cell line, exhibiting its highest antiproliferative activity (IC50¿=¿13.36¿µ¿) on the HuTu80¿cell line. Besides, 8 and 9 exhibited high antitumor activity (IC50¿=¿13.31 and 7.69¿µ¿, respectively) against the LNCaP cells.